Overview
Luigino Dal Maso-Maso practices practicing medicine in Aviano, Italy.
His clinical expertise encompasses Vulvar Cancer, Cryoglobulinemia, and Thyroid Cancer.
He is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Luigino D. Dal Maso-Maso
Is Luigino D. Dal Maso-Maso a top-rated expert for Vulvar Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Luigino D. Dal Maso-Maso is classified as an Experienced expert for Vulvar Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Luigino D. Dal Maso-Maso participate in research or clinical trials?
Yes. Luigino D. Dal Maso-Maso has published 16 articles and abstracts on conditions like Vulvar Cancer. You can view a list of Luigino D. Dal Maso-Maso's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CryoglobulinemiaMr. Dal Maso-Maso isExperienced. Learn about Cryoglobulinemia.
- Thyroid CancerMr. Dal Maso-Maso isExperienced. Learn about Thyroid Cancer.
- Vulvar CancerMr. Dal Maso-Maso isExperienced. Learn about Vulvar Cancer.